Decline in Stored Specimens and Business Performance Due to COVID-19
First written in FY2021. 3 of 5 entries say "Restated". Latest entry: FY2024-Q2.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2024-Q2MitigatedAnnual report
「In-person marketing, including speeches and public relations activities at medical institutions, primarily obstetric facilities, which are the company's main marketing channel and had been significantly restricted during the COVID-19 pandemic, recovered substantially and generated synergies with digital marketing, including online advertising and social media.」
The company explains that its main sales channels, which had been restricted by COVID-19, recovered substantially and generated synergies with digital marketing. The impact on sales channels is therefore trending downward. - FY2023RestatedAnnual report
「This was mainly because, amid restrictions on activity resulting from the spread of COVID-19, the cancellation and suspension of mothers' classes held at obstetric facilities cooperating in umbilical cord blood collection continued.」
Although activity restrictions resulting from the cancellation and suspension of mothers' classes continued, revenue reached a record high through web marketing and the umbilical cord storage service. - FY2023-Q1RestatedAnnual report
「The impact of COVID-19 on social and economic activity continued during the cumulative first quarter period, as well.」
The company recognizes that the impact of COVID-19 on social and economic activity is continuing. Meanwhile, revenue reached a record high during the quarter, and no new evidence of a decline in business performance was reported. - FY2022RestatedAnnual report
「Although the impact of COVID-19 on social and economic activity continued, the strengthening of digital marketing activities implemented since the previous fiscal year, together with Japan's first umbilical cord storage service launched in April of the previous year, contributed to record-high revenue.」
The company explains that, despite the continuing impact of COVID-19, it achieved record-high revenue through digital marketing and its umbilical cord storage service. - FY2021First statedAnnual report
「As a result, revenue was ¥1,409 million, a decrease of ¥266 million, or 15.9%, from the same period of the previous year. Operating profit was ¥86 million, down ¥295 million, or 77.3%. Ordinary profit was ¥92 million, down ¥290 million, or 75.8%. Net income was ¥62 million, down ¥215 million, or 77.5%.」
The annual number of specimens placed in storage was 5,695, compared with a target of 5,847. Both revenue and profit declined from the same period of the previous year.